Bibliography
Olaharski, A. J., Bitter, H., Gonzaludo, N., Kondru, R., Goldstein, D. M., Zabka, T. S., Lin, H., Singer, T., & Kolaja, K. (2010). Modeling Bone Marrow Toxicity Using Kinase Structural Motifs and the Inhibition Profiles of Small Molecular Kinase Inhibitors. Toxicological Sciences, 118(1), 266â275.
References
48
Referenced
12
10.1016/j.exphem.2008.10.009
/ Exp. Hematol. / A KIT juxtamembrane PY567 -directed pathway provides nonredundant signals for erythroid progenitor cell development and stress erythropoiesis (2009)10.1038/sj.leu.2404988
/ Leukemia / Pim2 complements Flt3 wild-type receptor in hematopoietic progenitor cell transformation (2008)10.1073/pnas.0805963106
/ Proc. Natl. Acad. Sci. U.S.A. / LOK is a major ERM kinase in resting lymphocytes and regulates cytoskeletal rearrangement through ERM phosphorylation (2009)10.1016/S0093-7754(01)90282-9
/ Semin. Oncol. / Tyrosine kinase inhibitors: rationale, mechanisms of action, and implications for drug resistance (2001)10.1182/blood-2007-04-083808
/ Blood / Pim-1 and Pim-2 kinases are required for efficient pre-B-cell transformation by v-Abl oncogene (2008)10.1016/j.gene.2006.07.009
/ Gene / Isolation and molecular characterization of the porcine transforming growth factor beta type I receptor (TGFBR1) gene (2006)10.1080/10428190310001641251
/ Leuk. Lymphoma / Increased expression of the hPim-2 gene in human chronic lymphocytic leukemia and non-Hodgkin lymphoma (2004)10.1038/leu.2008.221
/ Leukemia / Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase (2008)10.1056/NEJMoa062867
/ N. Engl. J. Med. / Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia (2006){'key': 'key\n\t\t\t\t20170508165812_bib10', 'volume-title': 'Cluster Analysis', 'year': '2001', 'edition': '4th ed'}
/ Cluster Analysis (2001)10.1038/nbt1068
/ Nat. Biotechnol. / A small molecule-kinase interaction map for clinical kinase inhibitors (2005)10.1111/j.1365-2184.2007.00438.x
/ Cell Prolif. / Inhibition of platelet-derived growth factor receptorbeta by imatinib mesylate suppresses proliferation and alters differentiation of human mesenchymal stem cells in vitro (2007)10.1189/jlb.0209097
/ J. Leukoc. Biol. / MAPK signaling pathways in the regulation of hematopoiesis (2009)10.1021/jm050736c
/ J. Med. Chem. / Discovery of S-[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxypropoxy)ph enyl]methanone (RO3201195), an orally bioavailable and highly selective inhibitor of p38 MAP kinase (2006){'key': 'key\n\t\t\t\t20170508165812_bib15', 'first-page': '679', 'article-title': 'A semi-mechanistic model of CP-690,550-induced reduction in neutrophil counts in patients with rheumatoid arthritis', 'volume': '50', 'year': '2009', 'journal-title': 'J. Clin. Pharmacol.'}
/ J. Clin. Pharmacol. / A semi-mechanistic model of CP-690,550-induced reduction in neutrophil counts in patients with rheumatoid arthritis (2009){'key': 'key\n\t\t\t\t20170508165812_bib16', 'first-page': '3519', 'article-title': 'Pivotal role for glycogen synthase kinase-3 in hematopoietic stem cell homeostasis in mice', 'volume': '119', 'year': '2009', 'journal-title': 'J. Clin. Invest.'}
/ J. Clin. Invest. / Pivotal role for glycogen synthase kinase-3 in hematopoietic stem cell homeostasis in mice (2009)10.3109/10428199609054832
/ Leuk. Lymphoma / Role of hepatocyte growth factor in hemopoiesis (1996)10.1182/blood.V97.7.1990
/ Blood / Basis of hematopoietic defects in platelet-derived growth factor (PDGF)-B and PDGF beta-receptor null mice (2001){'key': 'key\n\t\t\t\t20170508165812_bib19', 'volume-title': 'Finding Groups in Data: An Introduction to Cluster Analysis', 'year': '1990'}
/ Finding Groups in Data: An Introduction to Cluster Analysis (1990)10.1016/j.bbrc.2007.05.206
/ Biochem. Biophys. Res. Commun. / NEK7 is a centrosomal kinase critical for microtubule nucleation (2007)10.1002/art.24567
/ Arthritis Rheum. / The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo (2009)10.1074/jbc.272.36.22679
/ J. Biol. Chem. / LOK is a novel mouse STE20-like protein kinase that is expressed predominantly in lymphocytes (1997)10.1182/blood-2005-08-3470
/ Blood / A recombinant single-chain IL-7/HGFbeta hybrid cytokine induces juxtacrine interactions of the IL-7 and HGF (c-Met) receptors and stimulates the proliferation of CFU-S12, CLPs, and pre-pro-B cells (2006)10.1126/science.1075762
/ Science / The protein kinase complement of the human genome (2002)10.1158/0008-5472.CAN-08-0634
/ Cancer Res. / Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels (2008)10.1001/jama.295.21.2516
/ JAMA / Sunitinib in patients with metastatic renal cell carcinoma (2006)10.1093/annonc/mdg250
/ Ann. Oncol. / Phase I pharmacokinetic trial of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor gefitinib ('Iressa', ZD1839) in Japanese patients with solid malignant tumors (2003)10.1182/blood-2006-05-023093
/ Blood / Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors (2006)10.1080/10428190802322919
/ Leuk. Lymphoma / Inhibition of p38alpha MAPK disrupts the pathological loop of proinflammatory factor production in the myelodysplastic syndrome bone marrow microenvironment (2008)10.1371/journal.pcbi.1000446
/ PLoS Comput. Biol. / Identification of a kinase profile that predicts chromosome damage induced by small molecule kinase inhibitors (2009)10.1016/j.toxlet.2009.03.012
/ Toxicol. Lett. / In vitro to in vivo concordance of a high throughput assay of bone marrow toxicity across a diverse set of drug candidates (2009)10.1128/MCB.01867-08
/ Mol. Cell. Biol. / The Nek6 and Nek7 protein kinases are required for robust mitotic spindle formation and cytokinesis (2009){'key': 'key\n\t\t\t\t20170508165812_bib33', 'first-page': '1131', 'article-title': 'Phase II study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post polycythemia vera/essential thrombocythemia myelofibrosis', 'volume': '115', 'year': '2009', 'journal-title': 'Blood'}
/ Blood / Phase II study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post polycythemia vera/essential thrombocythemia myelofibrosis (2009)10.1002/cm.20039
/ Cell Motil. Cytoskeleton / Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cells (2004)10.1016/S0022-2836(02)00857-4
/ J. Mol. Biol. / Centrosomal anchoring of the protein kinase CK1delta mediated by attachment to the large, coiled-coil scaffolding protein CG-NAP/AKAP450 (2002)10.1172/JCI35636
/ J. Clin. Invest. / The PKC inhibitor AEB071 may be a therapeutic option for psoriasis (2008)10.1073/pnas.0602565103
/ Proc. Natl. Acad. Sci. U.S.A. / Differential requirement for Lck during primary and memory CD8+ T cell responses (2006)10.1146/annurev.cellbio.13.1.513
/ Annu. Rev. Cell Dev. Biol. / Cellular functions regulated by Src family kinases (1997){'key': 'key\n\t\t\t\t20170508165812_bib39', 'first-page': '1594', 'article-title': 'Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid restricted kinase, GRK6', 'volume': '115', 'year': '2009', 'journal-title': 'Blood'}
/ Blood / Kinome-wide RNAi studies in human multiple myeloma identify vulnerable kinase targets, including a lymphoid restricted kinase, GRK6 (2009)10.1359/jbmr.080409
/ J. Bone Miner. Res. / PDGF receptor beta is a potent regulator of mesenchymal stromal cell function (2008)10.1369/jhc.2009.954628
/ J. Histochem. Cytochem. / Analysis of cell type-specific expression of CK1 epsilon in various tissues of young adult BALB/c Mice and in mammary tumors of SV40 T-Ag-transgenic mice (2010)10.1016/S1359-6446(05)03477-X
/ Drug Discov. Today / Kinomics: characterizing the therapeutically validated kinase space (2005){'key': 'key\n\t\t\t\t20170508165812_bib43', 'first-page': '885', 'article-title': 'Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+)', 'volume': '26', 'year': '1998', 'journal-title': 'Exp. Hematol.'}
/ Exp. Hematol. / Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+) (1998)10.1007/s00277-008-0605-6
/ Ann. Hematol. / Regulation of FLT3 and its ligand in normal hematopoietic progenitor cells (2009)10.1007/s10528-009-9226-6
/ Biochem. Genet. / Molecular cloning, expression, and chromosomal mapping of the porcine CDC-2-like kinase 1 (CLK1) gene (2009)10.1016/j.febslet.2006.10.069
/ FEBS Lett. / Nek7 kinase is enriched at the centrosome, and is required for proper spindle assembly and mitotic progression (2006)10.1074/jbc.M412680200
/ J. Biol. Chem. / Calmodulin and calmodulin-dependent kinase IIalpha regulate osteoblast differentiation by controlling c-fos expression (2005)10.4161/cc.6.5.3921
/ Cell cycle / p38 MAP kinase regulates stem cell apoptosis in human hematopoietic failure (2007)
Dates
Type | When |
---|---|
Created | 14 years, 11 months ago (Sept. 1, 2010, 9:44 p.m.) |
Deposited | 5 years, 2 months ago (June 11, 2020, 12:44 a.m.) |
Indexed | 2 years, 3 months ago (May 20, 2023, 9:32 a.m.) |
Issued | 15 years ago (Sept. 1, 2010) |
Published | 15 years ago (Sept. 1, 2010) |
Published Online | 15 years ago (Sept. 1, 2010) |
Published Print | 14 years, 10 months ago (Nov. 1, 2010) |
@article{Olaharski_2010, title={Modeling Bone Marrow Toxicity Using Kinase Structural Motifs and the Inhibition Profiles of Small Molecular Kinase Inhibitors}, volume={118}, ISSN={1096-0929}, url={http://dx.doi.org/10.1093/toxsci/kfq258}, DOI={10.1093/toxsci/kfq258}, number={1}, journal={Toxicological Sciences}, publisher={Oxford University Press (OUP)}, author={Olaharski, Andrew J. and Bitter, Hans and Gonzaludo, Nina and Kondru, Rama and Goldstein, David M. and Zabka, Tanja S. and Lin, Henry and Singer, Thomas and Kolaja, Kyle}, year={2010}, month=sep, pages={266–275} }